Clinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-19

In December 2019 in Wuhan, China, the World Health Organization (WHO) declares that a severe pandemic of Coronavirus disease 2019 (COVID-19) was emerged and was spread rapidly resulted in dramatic global economic and health implications. The novel coronavirus, Severe Acute Respiratory Syndrome Coron...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Nikolaos Chrysanthakopoulos
Formato:	article
Lenguaje:	EN
Publicado:	Emergency Department of Hospital San Pedro (Logroño, Spain) 2020
Materias:	infection coronavirus covid-19 cancer patients Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/10e539432d7148dab20422809b518a84
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:10e539432d7148dab20422809b518a84
record_format	dspace
spelling	oai:doaj.org-article:10e539432d7148dab20422809b518a842021-12-02T19:14:49ZClinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-1910.5281/zenodo.40388192695-5075https://doaj.org/article/10e539432d7148dab20422809b518a842020-09-01T00:00:00Zhttps://doi.org/10.5281/zenodo.4038819https://doaj.org/toc/2695-5075In December 2019 in Wuhan, China, the World Health Organization (WHO) declares that a severe pandemic of Coronavirus disease 2019 (COVID-19) was emerged and was spread rapidly resulted in dramatic global economic and health implications. The novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is responsible for a severe inflammatory reaction and clinically severe complications, although the majority of the infected individuals had mild symptoms and favorable prognosis after recovery. However, cancer patients are a high-risk group as are already susceptible to COVID-19 infection due to their underlying disease and their immunosuppression. Moreover, cancer patients are at increased risk of developing clinically severe complications in case of COVID-19 infection such as, Intensive Care Unit admission, required mechanical ventilation or even death. Another aggravating factor for oncological patients, during that pandemic crisis is the risk of postponing cancer treatment. The present review presents the clinical characteristics accompanied by the corresponding laboratory findings in COVID-19 infected cancer patients and the possible therapeutic role of some known chemo-therapeutic agents based on the recent observations of the International literature.Nikolaos ChrysanthakopoulosEmergency Department of Hospital San Pedro (Logroño, Spain)articleinfectioncoronaviruscovid-19cancerpatientsMedicine (General)R5-920ENIberoamerican Journal of Medicine, Vol 2, Iss 4, Pp 367-373 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	infection coronavirus covid-19 cancer patients Medicine (General) R5-920
spellingShingle	infection coronavirus covid-19 cancer patients Medicine (General) R5-920 Nikolaos Chrysanthakopoulos Clinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-19
description	In December 2019 in Wuhan, China, the World Health Organization (WHO) declares that a severe pandemic of Coronavirus disease 2019 (COVID-19) was emerged and was spread rapidly resulted in dramatic global economic and health implications. The novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is responsible for a severe inflammatory reaction and clinically severe complications, although the majority of the infected individuals had mild symptoms and favorable prognosis after recovery. However, cancer patients are a high-risk group as are already susceptible to COVID-19 infection due to their underlying disease and their immunosuppression. Moreover, cancer patients are at increased risk of developing clinically severe complications in case of COVID-19 infection such as, Intensive Care Unit admission, required mechanical ventilation or even death. Another aggravating factor for oncological patients, during that pandemic crisis is the risk of postponing cancer treatment. The present review presents the clinical characteristics accompanied by the corresponding laboratory findings in COVID-19 infected cancer patients and the possible therapeutic role of some known chemo-therapeutic agents based on the recent observations of the International literature.
format	article
author	Nikolaos Chrysanthakopoulos
author_facet	Nikolaos Chrysanthakopoulos
author_sort	Nikolaos Chrysanthakopoulos
title	Clinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-19
title_short	Clinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-19
title_full	Clinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-19
title_fullStr	Clinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-19
title_full_unstemmed	Clinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-19
title_sort	clinical characteristics and laboratory findings in coronavirus disease 2019 (covid-2019) infected cancer patients and chemotherapeutic medicines against covid-19
publisher	Emergency Department of Hospital San Pedro (Logroño, Spain)
publishDate	2020
url	https://doaj.org/article/10e539432d7148dab20422809b518a84
work_keys_str_mv	AT nikolaoschrysanthakopoulos clinicalcharacteristicsandlaboratoryfindingsincoronavirusdisease2019covid2019infectedcancerpatientsandchemotherapeuticmedicinesagainstcovid19
_version_	1718376955737276416

Clinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-19

Ejemplares similares